The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal multicenter study designed to develop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tracking of Alzheimer’s disease (AD). Since its launch more than a decade ago, the landmark public-private partnership has made major contributions to AD research, enabling the sharing of data between researchers around the world.Data from several dementia studies complementary to ADNI are also available through the IDA. These include the DoD-ADNI study, which measures the effects of traumatic brain injury and post-traumatic stress disorder on Alzheimer’s disease in veterans, and the AIBL study (Australian Imaging Biomarkers and Lifestyle Study of Aging).
View Resource
